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Background: The mechanisms responsible for calorie restriction (CR)-induced
improvement in insulin sensitivity (IS) have not been fully elucidated. Greater insight
can be achieved through deep biological phenotyping of subjects undergoing CR, and
integration of big data.
Materials and Methods: An integrative approach was applied to investigate
associations between change in IS and factors from host, microbiota, and lifestyle after a
6-week CR period in 27 overweight or obese adults (ClinicalTrials.gov: NCT01314690).
Partial least squares regression was used to determine associations of change (week
6 – baseline) between IS markers and lifestyle factors (diet and physical activity),
subcutaneous adipose tissue (sAT) gene expression, metabolomics of serum, urine and
feces, and gut microbiota composition. ScaleNet, a network learning approach based
on spectral consensus strategy (SCS, developed by us) was used for reconstruction of
biological networks.
Results: A spectrum of variables from lifestyle factors (10 nutrients), gut microbiota
(10 metagenomics species), and host multi-omics (metabolic features: 84 from serum,
73 from urine, and 131 from feces; and 257 sAT gene probes) most associated
with IS were identified. Biological network reconstruction using SCS, highlighted links
between changes in IS, serum branched chain amino acids, sAT genes involved in
endoplasmic reticulum stress and ubiquitination, and gut metagenomic species (MGS).
Linear regression analysis to model how changes of select variables over the CR period
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contribute to changes in IS, showed greatest contributions from gut MGS and fiber
intake.
Conclusion: This work has enhanced previous knowledge on links between host
glucose homeostasis, lifestyle factors and the gut microbiota, and has identified potential
biomarkers that may be used in future studies to predict and improve individual response
to weight-loss interventions. Furthermore, this is the first study showing integration of
the wide range of data presented herein, identifying 115 variables of interest with respect
to IS from the initial input, consisting of 9,986 variables.
Clinical Trial Registration: clinicaltrials.gov (NCT01314690).
Keywords: data integration, insulin sensitivity, lifestyle factors, microbiota, omics
INTRODUCTION
Obesity-associated impairment of glucose homeostasis is
influenced by multiple elements including diet, physical activity,
pharmacology and other lifestyle factors, predisposition from
the host due to genetics, epigenetics, physiology and, as
discovered more recently, gut microbiota alterations (Mutch
and Clément, 2006; Khan et al., 2014; Mozaffarian, 2016).
Although these elements have been implicated in different facets
of the etiology of type 2 diabetes (T2D), specific mechanisms
showing how they interact remain partially understood. Through
high-throughput generation of biological data and analytical
approaches involving data integration of elements from
multiple sources, we endeavored to shed light on these complex
interactions and highlight relevant mechanistic pathways.
Gut microbiota composition and function may play an
important role in the prevention but also progression of insulin
resistance (Qin et al., 2012; Cotillard et al., 2013; Karlsson
et al., 2013; Le Chatelier et al., 2013; Dao et al., 2015; Forslund
et al., 2015; Pedersen et al., 2016). Some bacterial species, such
as Akkermansia muciniphila and Faecalibacterium prausnitzii,
as well as high gut microbial gene richness are known to be
associated with better metabolic and intestinal health (Cotillard
et al., 2013; Le Chatelier et al., 2013; Dao et al., 2015; Plovier
et al., 2017). Interestingly, studies considering the microbiome’s
functional potential have identified a series of pathways that
are linked with different stages of insulin resistance. Among
these pathways, branched chain amino acid (BCAA) metabolism
by microbiota stands out. A recent study of the metagenome
Abbreviations: AAAs, aromatic amino acids; ALDH6A1, aldehyde dehydrogenase
6 family, member A1; AT, adipose tissue; BCAT2, branched chain amino acid;
transaminase 2; BCAA, branched chain amino acid; BCKDH complex, branched
chain ketoacid dehydrogenase; BCKDHA, branched chain ketoacid dehydrogenase
E1; BH, Benjamini-Hochberg; BMI, body mass index; CR, calorie restriction; DBT,
dihydrolipoamide branched chain transacylase E2; DDRGK1, DDRGK domain
containing 1; FIRI, fasting insulin resistance index; HOMA-B, homeostasis model
assessment of beta cell function; HOMA-IR, homeostasis model assessment of
insulin resistance; HOMA-S, homeostasis model assessment of insulin sensitivity;
IL-6, interleukin-6; IS, insulin sensitivity; MGS, metagenomic species; MSE, mean
squared error; NEFAs, non-esterified fatty acids; NF-κB, nuclear factor-κB; non-
HDL, non-high density lipoprotein = total cholesterol – HDL; PLSR, partial
least squares regression; pSVA, permuted-surrogate variable analysis; QUICKI,
quantitative insulin sensitivity check index; revised QUICKI, revised quantitative
insulin sensitivity check index; sAT, subcutaneous adipose tissue; SCS, spectral
consensus strategy; T2D, type 2 diabetes; UFM1, ubiquitin-fold modifier 1.
found increased abundance of bacterial genes coding for BCAA
production and decreased abundance of genes coding for BCAA
transporters on the bacterial wall in relation to insulin resistance
in non-diabetic Danish adults (Pedersen et al., 2016).
High circulating concentrations of BCAA may disrupt glucose
homeostasis in situations of stress on the body such as in high
caloric intake (especially high-fat diets) or diets rich in foods
with high glycemic index and excess body weight (Newgard
et al., 2009; Roberts et al., 2014). BCAA have been repeatedly
found to be elevated in T2D and obesity, and have been
considered as early predictors of T2D (Roberts et al., 2014).
Through activation of the nutrient-sensitive mTOR pathway
and shift toward anabolism, BCAA may be redirected from
protein synthesis toward gluconeogenesis with disruption of
glucose homeostasis partly through chronically increased insulin
secretion. Excessive fat mass storage in obesity may lead to
not only in situ metabolic disruption, with some evidence of
decreased BCAA catabolism (Roberts et al., 2014), but also
ectopic fat deposition and inflammation. These modifications
play an important role in the development of insulin resistance.
Lifestyle interventions resulting in weight loss, which involve
calorie restriction (CR) together with improved dietary quality,
and increased physical activity, lead to amelioration of IS
(Després et al., 2001; Speakman and Mitchell, 2011; Kong et al.,
2013). However, response to these interventions greatly varies
from one person to another and a greater understanding at the
individual level is needed to predict and enhance response (Kong
et al., 2013; Dao et al., 2016). CR has been shown to significantly
modify the transcriptional gene profile in subcutaneous adipose
tissue (sAT) (Clément et al., 2004; Viguerie et al., 2005; Capel
et al., 2009; Rizkalla et al., 2012), as well as other AT depots, and
to modulate microbiota composition and function (reviewed in
Dao et al., 2016).
So far, knowledge about the relationship between lifestyle
factors, host biology, gut microbiota and gut-derived metabolites
is somewhat fragmented. A better understanding of their
interconnection may be achieved through data integration
approaches across different disciplines of biological sciences
and medicine (Kussmann et al., 2013; Kidd et al., 2014; Wu
et al., 2015; Dao et al., 2016), and great efforts to develop
data integration methods are currently being undertaken. Data
integration can provide greater biological insight, a better
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understanding of relationships between variables, and may lead
to innovative data-driven hypotheses paving the way to the
discovery of mechanistic links. In fact, new data integration
approaches are increasingly required to analyze the vast amounts
of data being collected from deep phenotyping of patients
(Piening et al., 2018).
The goal of this study was to improve our understanding of
the inter-connectivity of IS and lifestyle, gut microbiome and host
factors through the use a data integration approach. We aimed
to conduct an in-depth exploration of associations between CR-
induced improvement in IS and changes in host biology, gut
microbiota and lifestyle factors. Novel connections between these
elements were identified.
MATERIALS AND METHODS
Study Population and Dietary
Intervention
A subgroup (N = 27) of the MICRO-Obes study (Cotillard
et al., 2013; Kong et al., 2013, 2014) has been included in this
report, based on AT sample availability. All analyses have been
conducted using the delta (week 6 – baseline) of the different
variables. The participants were overweight and obese adults [3
men and 24 women, median [interquartile range (IQR)] age
and BMI: 41 (26) years and 33.9 (5.8) kg/m2] with no chronic
conditions and no medication use. The dietary intervention was
completed at the Pitié-Salpêtrière Hospital in Paris, France and
consisted of a 6-week individually prescribed hypocaloric diet
(1200 kcal/d for women and 1500 kcal/d for men) followed by a
6-week weight-maintenance period. Only information collected
at baseline and week 6 of the intervention has been included in
the present analysis. This diet consisted of habitually consumed
foods plus meal replacement with four dietary products daily
(60–75 kcal; designed by CEPRODI-KOT Laboratory). These
supplements consisted of lyophilized powder enriched in protein
and soluble fiber (mainly inulin) and composed of low glycemic
index carbohydrates. This intervention has been previously
described in detail (Rizkalla et al., 2012; Kong et al., 2013). This
study has been registered in ClinicalTrials.gov (NCT01314690)
and approved by the Ethical Committee of Hôtel-Dieu Hospital
in Paris, France in 2008 (under the number 0811792). All
participants provided written informed consent. Data collection
occurred in 2009 and 2010.
Assessment of Clinical Parameters
Body composition, sAT adipocyte diameter, and fasting blood
lipids, insulin, glucose, inflammatory markers, and IS/secretion
markers were assessed as described previously (Dao et al.,
2015). Body composition measures included anthropometric
measurements (weight, height, waist, and hip circumference),
and dual energy X-ray (DXA) absorptiometry. Blood samples
were collected after a 12-h fast.
Assessment of Food and Drink Intake
Diet was assessed with a 7-day unweighted food diary
administered at baseline and week 6, as previously described in
Kong et al. (2014). The software PROFILE DOSSIER V3 was
used for analysis of the diaries and consumed foods were grouped
into 26 food groups according to French dietary surveys. Average
intake of energy, nutrients, and food groups were calculated from
intake over the 7 days. The PROFILE DOSSIER X029 computer
software (Audit Conseil en Informatique Médicale, Bourges,
France) was used to analyze all food diaries and generate nutrient
intakes. This software has a food composition database consisting
of 400 food items which are representative of the French diet
(Bouché et al., 2002).
Change in Diet and Clinical Variables
Changes in clinical and diet data were estimated using SAS
9.4. Median and IQR are reported for all variables. Statistical
significance in change in clinical outcomes was determined with
Wilcoxon signed rank sum test. Correction for multiple testing
per class of variable was done using BH with FDR at the 5% level,
and adjusted P-values are reported. Post hoc statistical power
calculations for the change in IS markers from baseline to week 6
of CR is presented in Supplementary Table 1.
Adipose Tissue Biopsies and Gene
Expression With Microarray Analysis
Subcutaneous adipose samples were collected at baseline and
week 6 by needle biopsy from the periumbilical region under
local anesthesia. Samples were frozen rapidly in liquid nitrogen
then stored at −80◦C until they were further processed for
microarray analysis as described in Rizkalla et al. (2012). Briefly,
total RNA was extracted by using the RNeasy total RNA Mini kit
(QIAGEN) with one-column DNase digestion. RNA quality and
concentration were assessed by using an Agilent 2100 Bioanalyzer
(Agilent Technologies). An Illumina RNA amplification kit
(Ambion) was used according to the manufacturer’s instructions
to obtain biotin-labeled complementary RNA from 250 ng
total RNA. Hybridization processes were performed with
Illumina Human HT-12 version 3.0 Expression BeadChips
(Illumina, Inc.). Hybridized probes were detected with cyanin-3-
streptavidin (1 mg/mL; Amersham Biosciences, GE Health Care)
and scanned by using an Illumina BeadArray Reader. Raw data
were extracted with GenomeStudio 2011.1 Software by using
the default settings and quantile normalization. Relevant genes
associated with changes in IS were annotated using the FunNet
tool (Prifti et al., 2008), using the whole human genome as the
reference gene set.
Batch Correction of Microarray Data
Transcriptomics data were adjusted for batch effects that are
technical artifacts inherent to DNA/RNA sample processing
(Supplementary Figure 1A) (Leek et al., 2010). We chose the
pSVA approach (Chen et al., 2011; Parker et al., 2014), to
remove these effects based on an in-house micro-array quality
control procedure. The pSVA adjustment method, which is based
on singular value decompositions, has been shown to be very
efficient in preserving biological heterogeneity (Parker et al.,
2014).
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We have evaluated the adjustment quality of our data
following the approach described in Gagnon-Bartsch and Speed
(Gagnon-Bartsch and Speed, 2012). Specifically, two sets of
control genes have been determined from the literature and
narrowed down by statistical analysis: positive controls (18
genes) that were shown to be differentially expressed between
male and female AT, and negative controls (47 genes) whose
expression is independent of the gender biological signal
(Supplementary Figures 1B,C). P-value rank of controls were
assessed before and after batch effect correction to identify the
optimal adjustment approach (Supplementary Figures 1D,E).
A complementary qPCR analysis confirmed the batch effect
correction improvement (Supplementary Figures 1F,G). The
final data set included only genes that were 100% present in all
27 subjects at both time points.
Analysis of sAT Gene Expression by
qPCR
RNAs from AT were prepared using RNeasy Lipid Tissue kit
(Qiagen) and cDNAs were synthesized using SuperScript II and
random hexamers (Promega). Quantitative PCR with SybrGreen
was performed and relative quantification of each transcript in
comparison to 18S was determined using the 2−11Ct method.
All primer sequences are available upon request.
Metagenomic Sequencing for
Assessment of Gut Microbiota
Fecal microbiota was characterized with shotgun quantitative
metagenomics (N = 27). Total fecal DNA was analyzed with high
throughput SOLiD sequencing, as described in Cotillard et al.
(2013). Reads were mapped and counted onto the 3.9 million
gene catalog, as described in Dao et al. (2015). Only MGS with
more than 700 genes were considered.
Serum and Urine Metabolic Phenotyping
by 1H NMR Spectroscopy
Urine (N = 21) and serum (N = 24) samples were randomized,
prepared and measured on a NMR spectrometer (Bruker)
operating at 600.22 MHz 1H frequency using previously
published experimental parameters (Dona et al., 2014). The 1H
NMR spectra were then pre-processed and analyzed as previously
reported (Dumas et al., 2006) using Statistical Recoupling of
Variables-algorithm (Blaise et al., 2009). Structural assignment
was performed as reviewed in Dona et al. (2016), using in-house
and publicly available databases.
Fecal Metabolomics
Analysis of frozen fecal samples (N = 26) from patients was
performed using an Agilent 7890A gas chromatography system
coupled to an Agilent 5975C inert XL EI/CI MSD system (Agilent,
Santa Clara, CA, United States). A HP-5MS fused-silica capillary
column (30 m × 250 µm × 0.25 µm; Agilent J & W Scientific,
Folsom, CA, United States) was used. Sample preparation and
GC/MS methods were performed as detailed in the paper of
Gao et al. (2009). Peaks obtained from fecal water samples were
aligned, grouped and corrected according to the mass to charge
ratio (m/z) and retention time using XCMS R tools (Smith
et al., 2006). Resulting MS data was a data matrix in which 835
features were found and characterized by a retention time (RT),
mass to charge ratio (m/z) and their corresponding intensities
per patient. Spectra were deconvoluted using Automated Mass
Spectral Deconvolution and Identification System (AMDIS)
before being compared with reference libraries (in-house and
NIST05). Annotation and identification of features were based
on standards proposed by Sumner et al. (2007). Eighty-five
features were found statistically relevant and identified based
on the retention time, m/z and reference spectra of standards
from a local database. Features were considered as putatively
annotated when only the m/z and RT and main fragments
were matched with the reference standards. The remaining
features were putatively characterized (m/z and RT were verified
with metabolites in our local database) or noted as unknown
features.
Inputs From Host, Lifestyle, and
Microbiota for Partial Least Squares
Regression Analysis
A large set of variables measured from elements in host,
lifestyle patterns or microbiota have been included in the data
integration analysis presented herein. Specifically, as shown
in Figure 1A, the following numbers of variables have been
included: 26 food groups and 34 nutrients derived from 7-
day food diaries, three physical activity variables obtained from
the validated Baecke questionnaire, 741 MGS derived from
metagenomic sequencing, 835 features from fecal metabolic
features obtained using GC–MS, 562 urine and 180 serum
metabolic features measured with NMR, 45 clinical parameters
(including anthropometric measures, markers of IS, circulating
concentrations of lipids, inflammatory markers, adipokines,
creatine, and cystatin C, and adipocyte diameter measured from
sAT biopsies).
Partial Least Squares Regression With
Canonical Mode
Multivariate methods such as PLSR are well-suited and often
applied to big biological data, including situations where the
number of variables (clinical parameters, metabolic features,
genes, etc.) is much larger than the number of observations
(patients). In particular, PLSR is used to model relationships
between two groups of variables (Esposito Vinzi et al., 2010).
It maximizes the covariance between latent variables which are
linear combinations of the observed pairs of variable groups.
The results can be efficiently visualized as graphs that enable
better understanding of underlying biological relations and
processes. In our analysis, we have used the R “mixOmics”
package (Omics Data Integration Project), and the function pls(),
with the mode = “canonical,” which assumes no directional
relationships between data sets. PLSR usually refers to an
asymmetric deflation of the two groups of variables, if the
deflation is symmetric, then the mode is called canonical
mode. A threshold between | 0.7| and | 0.75| for association
coefficients was set in order to only consider the strongest
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FIGURE 1 | Analysis pipeline for data integration. (A) Groups of variables from host, gut microbiota, and lifestyle were considered as input for this analysis.
Specifically, the inputs were changes (week 6 – baseline) in the following blocks of variables: clinical parameters (N = 45), including 10 markers of IS/resistance
( ), ¶ lifestyle factors (food groups, N = 26, nutrients N = 34, and physical activity, N = 3), · MGS (N = 741, i.e., with more than 700 genes), ¸ fecal metabolic
features (N = 835), ¹ urine metabolic features (N = 562), º serum metabolic features (N = 180), and » sAT gene expression (N = 7,560 ILMN probes). (B) Two
blocks of variables at a time were analyzed using PLSR with canonical mode (MixOmics R package). We have analyzed changes in versus changes in ¶ through
º, and between and ». Association coefficient threshold = | 0.7| was selected for analysis with ¶ and ·, and | 0.75| for analysis with ¸, ¹, º and ». An example
of a PLSR network between blocks and º is shown. (C) The associations between and host, microbiota, or lifestyle were interpreted. (D) From the PLSR
output, the features most strongly associated with improvement in IS after CR were selected (top 20% variables from each PLSR). (E) Visualization of selected
features in network reconstruction using SCS (ScaleNet, developed by our group). In hypothetical network shown in E, red nodes: microbiota; blue nodes: host;
green nodes: lifestyle factors. Arrows refer to dependency directionality.
connections between each variable block and IS. Networks
from PLSR were generated using Cytoscape (Shannon et al.,
2003).
Spectral Consensus Strategy for
Accurate Reconstruction of Large
Biological Networks
Developing statistical methods to accurately reconstruct
biological interaction networks is a central goal of integrative
systems biology (Herrgård et al., 2008). In the networks that
are of interest in our analysis, nodes represent variables and
edges indicate statistical dependency. While many network
reconstruction methods exhibit competitive results on various
types of data, most state-of-the art methods are challenged to
scale to very high dimension datasets where the number of
variables might be several orders of magnitude larger than the
number of observations. In our analysis, this is precisely the
setting we encounter as the number of variables is 9,986 and the
number of observations is 27.
To accurately reconstruct such a network of interactions we
have developed an original method (Affeldt et al., 2016) that first
reduces the reconstruction problem into a large number of much
simpler reconstruction problems, then let the lower-dimension
problem be solved by state-of-the art reconstruction methods
and finally adopt a consensual voting strategy between these
methods to identify the most accurate sub-graphs. The different
sub-graphs are then connected when they share common nodes
like pieces of a larger puzzle. The main originality of the method
lies in its powerful problem reduction that, thanks to a so-
called spectral decomposition, both identifies non-exclusive sets
of most likely dependent variables and enables the approach
to scale-up to large biological networks. ScaleNet networks
were generated using Cytoscape (Shannon et al., 2003). For the
network presented herein, we used 14% of the eigenvector, and
the size of the subgraphs used for the reconstruction was 0.03.
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Prediction and Regression
The target variables being predicted (i.e., revised QUICKI index
and HOMA-B as markers of IS) are continuous, therefore, we
performed a linear regression to estimate the impact of each set
of independent of variables on the variable of interest. The MSE
provides the average of the squares of the errors of deviations,
and quantifies the difference between the real and estimated data.
To measure the impact of each data source on IS, we ran linear
regressions and computed the MSE for each type of data (10-fold
cross validation) (Hastie et al., 2009). We inferred that the inverse
values of the MSE represent the magnitude of the impact. The
intuition behind such a visualization is that the lower the error,
the more significant the data are.
Analysis of Subcutaneous Adipose
Tissue DDRGK1 in a Separate Obese
Population
To explore some of the novel links identified with PLSR and
ScaleNet, we used existing data from an unpublished CR study
and determined association between sAT DDRGK1 and IS. The
methodologies for these variables were the same that in the
present study. The validation study consisted of a 6-week very
low calorie diet, followed by 6 weeks of weight stabilization. In
this group of overweight/obese adults, only baseline and week 12
values (i.e., after the weight regain and stabilization period) are
presented.
Availability of Data
Data used in this manuscript can be accessed as follows:
(1) AT Illumina microarray data with Gene Expression
Omnibus (GSE112307), (2) serum metabolomics NMR
data with Metabolights (pending accession code), (3) urine
metabolomics NMR data with Metabolights (pending accession
code), (4) fecal metabolomics GC–MS data with Metabolights
(MTBLS653), and (5) metagenomics raw solid read data with the
European Bioinformatics Institute European Nucleotide Archive
(ERP003699).
RESULTS
Dietary Intervention-Induced Weight
Loss and Improved Insulin Sensitivity:
Multiple Inputs Used for Data Analysis
and Integration
Figure 1 shows an overview of the different steps taken to analyze
the data presented in this study. Details are provided in Section
“Materials and Methods.” The study population is a subgroup
from the MICRO-Obes study (Cotillard et al., 2013; Kong et al.,
2013, 2014), consisting of 27 overweight or obese adults who
underwent a 6-week CR intervention (1,200 kcal/day for women
and 1,500 kcal/day for men). The diet was low in fat (25%
of energy intake), high in protein (35% of energy intake), and
rich in total fiber and in carbohydrates with a low glycemic
index. The diet composition has been described elsewhere
(Rizkalla et al., 2012). The variable inputs as described previously
(Cotillard et al., 2013; Kong et al., 2013, 2014), were divided
into the following blocks (Figure 1A): 45 clinical variables
that included anthropometry, adipocyte diameter, measures from
blood chemistry profiles (including 10 IS markers, ), and
inflammatory markers; ¶ lifestyle factors (26 food groups,
34 macro- and micronutrients, 3 indexes representing degree
of physical activity at work, sports and leisure time); · 741
MGS; ¸ 835 fecal metabolic features; ¹ 562 urine metabolic
features; º 180 serum metabolic features; and » 7,560 genes
expressed in sAT. The change (week 6 – baseline) in each
variable was exclusively used in all analytical steps (Figures 1B–
E).
TABLE 1 | Change in clinical outcomes with calorie restriction.
Baseline Week 6
Variable Number Median IQR Median IQR Padj
Age 27 41 26
Sex M 3
F 24
BMI (kg/m2) 27 33.9 5.8 31.9 5.9 1.3E-08
Hip circumference
(cm)
27 118 12 114 15 4.17E-08
Waist
circumference (cm)
27 107 14 99 13 7.4E-07
Waist-to-Hip ratio 27 0.92 0.12 0.89 0.13 0.0217
Fat mass (%) 27 42.7 6.9 41.6 6.1 0.0002
Fat free mass (%) 27 54.3 6.6 55.5 6.2 0.0005
Android fat (%) 27 59.4 8.3 57.7 9.5 0.0117
Gynoid fat (%) 27 38.5 7.8 38.6 9.8 0.0383
Adipocyte diameter
(µm)
27 110.9 11.5 101.7 6.1 1.3E-08
Serum triglycerides
(mM)
27 1.08 0.63 0.82 0.53 0.0010
NEFA (mM) 27 0.49 0.29 0.50 0.32 0.0485
Cholesterol (mM) 27 5.21 1.27 4.66 1.03 4.63E-05
HDL (mM) 27 1.35 0.50 1.11 0.41 0.0002
LDL (mM) 27 3.30 0.99 2.97 0.94 0.0016
CRP (mg/L) 27 3.60 5.25 3.12 4.17 0.40
IL-6 (pg/ml) 27 1.24 1.48 1.47 1.10 0.97
Insulin (µUI/ml) 27 8.6 5.1 5.7 3.7 1.3E-08
Glucose (mM) 27 5.1 0.5 5.0 0.4 0.0032
Insulin : Glucose 27 1.75 0.90 1.27 0.48 0.0005
HOMA2-IR 27 1.15 0.71 0.74 0.48 1.3E-08
HOMA2-B 27 94.0 30.9 78.3 32.9 5.06E-05
HOMA2-S 27 87.1 68.2 135.2 83.5 1.67E-08
FIRI 27 1.93 1.19 1.12 0.77 1.3E-08
Disse Index 27 -6.7 4.5 -4.1 6.8 0.06
QUICKI 27 0.34 0.04 0.37 0.04 1.3E-08
Revised QUICKI 27 0.39 0.06 0.41 0.05 0.12
Wilcoxon signed rank sum test, adjusted P-values (Padj, BH correction) are
shown. BMI, body mass index; NEFA, non-esterified fatty acids; HDL, high density
lipoprotein; LDL, low density lipoprotein; CRP, C-reactive protein; IL-6, interleukin-
6; FIRI, new fasting insulin resistance index; revised QUICKI, revised quantitative
insulin sensitivity check index; IQR, interquartile range. Bold values are significant
adjusted p-values.
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As expected, the dietary intervention led to a significant
reduction in BMI, with an average weight loss of 5.4 ± 2.5%, as
well as waist-to-hip ratio, % fat mass and android fat (Table 1).
There was a significant decrease in blood lipids, and a marked
improvement in surrogate markers of insulin secretion (HOMA-
B, calculated as described in Levy et al., 1998); or IS (HOMA
of insulin resistance, HOMA-IR, HOMA-S, Disse index, the
quantitative IS check index, QUICKI, the revised QUICKI,
insulin to glucose ratio, and the new FIRI, Table 1). It is
important to note that there was a wide range of change in IS,
with both responders and non-responders to the intervention,
as is commonly the case with lifestyle and CR interventions
(Kong et al., 2013). Indeed, while all participants experienced
a decrease in BMI during this period, there was individual
variability in change of the revised QUICKI, with 19 individuals
having an increase (improving IS as measured by this index) and
8 individuals having a decrease in this index. As such there was
no significant improvement in mean revised QUICKI (Table 1).
Supplementary Figure 2 shows individual trajectories for IS
indexes used in the analysis.
Change in Insulin Sensitivity After
Diet-Induced Calorie Restriction:
Association With a Myriad of Lifestyle,
Gut Microbiota, Metabolic Features, and
Adipose Tissue Genes
Using PLSR with canonical mode, we examined association
networks between the changes in IS from this CR intervention
and changes in lifestyle factors (i.e., diet and physical activity),
blood, urine, and fecal metabolomics, gut metagenomics, and
sAT transcriptomics. Although there is redundancy in some of
the IS markers, they were included to ensure analytical relevance.
In other words, we would expect similar indexes such as FIRI
and HOMA-IR to be associated with consistent sets of variables
(which was the case, as seen in Supplementary Figure 3).
The networks depicting PLSR results (Figures 2A,B) show
strong associations of change between several groups of variables
and IS markers. We considered association coefficients greater
than | 0.7| or, in some cases, | 0.75| . These thresholds represent
a trade-off between analytical stringency and retention of
useful information (Supplementary Table 2). Above the selected
thresholds, there were associations between improvements in IS
and change in nutrient intake that included fiber, carbohydrate,
alcohol, β-carotene, vitamins A, B6, and B9, magnesium,
phosphorus, and iron (Figure 2C and Supplementary Figure 4A,
Supplementary Table 3). No food groups were associated with IS
above the selected threshold.
Regarding gut microbiota changes, 10 MGS, each detected in
at least two subjects, were associated (in some cases negatively
and in others positively) with improvement in IS after CR. Three
of these MGS have not been annotated at any taxonomic level
(Figure 2C). Of the annotated ones, when considering the lowest
taxonomic annotation available, one was related to the species
Collinsella intestinalis (having negative association of change with
revised QUICKI). At the genus level there were two Alistipes
(having positive association of change with revised QUICKI,
Disse index or glucose), one Bacteroides and one Prevotella
(both having positive association of change with glucose). At the
family level one Lachnospiraceae (having negative association of
change with glucose); and at the order level one Clostridiales
(having negative association of change with revised QUICKI)
(Supplementary Figure 4C). Of the unannotated MGS, there
was one having a negative association of change with the
Disse index (Best Hit: uncultured Faecalibacterium sp.), and
two having a negative association of change with fasting
glucose (Best Hit: Opitutaceae bacterium TAV5 and uncultured
Faecalibacterium sp.).
There were 84 serum metabolic features whose changes in
concentration were most strongly associated (81 negatively and
3 positively) with improvement in IS. Among these were BCAA
and AAAs, as well as other amino acids, namely lysine, glutamate,
and glutamine (Figure 2C and Supplementary Figure 4B).
IS improvement was associated with a decrease in BCAA,
consistent with the literature (Roberts et al., 2014). Several
explanations could account for the implication of BCAA in
glucose homeostasis. One hypothesis is the potential role of AT,
which has been shown to have decreased expression of BCAA
catabolic enzymes in obesity and insulin resistance (Roberts
et al., 2014). In agreement with this hypothesis, the PLSR
analysis between variation in serum metabolic features and sAT
transcriptomics show strong significant associations between sAT
genes and BCAA as well as with other metabolites including 3-
hydroxyisobutyrate and 3 methyl-2-oxovalerate (Supplementary
Figure 5). When considering change in AT genes coding
for enzymes involved in BCAA catabolism (Supplementary
Figure 5F) (Herman et al., 2010), there was a positive association
of change between valine and isoleucine with the BCAT2 gene.
This enzyme converts BCAA into α-ketoacids in the first step of
BCAA catabolism (Herman et al., 2010). There was a negative
association between all BCAA and gene expression of DBT,
which is part of the BCKDH complex. This complex catalyzes
the second step of BCAA catabolism, namely the conversion of
α-ketoacids into acyl-CoA esters. Only isoleucine was positively
associated with BCKDHA, which is also part of the BCKDH
complex. ALDH6A1, involved in a downstream step of the
pathway, was also negatively associated with variations in all
BCAA. These results suggest that while substrates to the first step
of BCAA catabolism may decrease with weight loss, subsequent
steps of the pathway increase, reflecting an upregulation of BCAA
catabolism.
In urine, change in hippurate, a metabolite previously found
to be inversely associated with metabolic syndrome risk, gut
microbiota richness (Pallister et al., 2017), and obesity (Elliott
et al., 2015), was positively associated with improvement in IS,
specifically, with a decrease in plasma insulin, HOMA-IR and
FIRI (Supplementary Figure 4B). Fecal metabolites associated
with change in IS included isoleucine, alanine, β-alanine, 2-
hydroxyhexanoic acid, arabinose methoxyamine, valeric acid,
phenylacetic acid, 3-hydroxypyridine, 4-cresol, malonic acid, and
lactate (Supplementary Figure 4B).
PLSR analysis also revealed that the clinical factors most
strongly associated with AT genes were Disse, QUICKI, FIRI and
revised QUICKI indexes, NEFAs, non-HDL, adipocyte diameter,
interleukin-6 (IL-6), BMI, hip circumference and fat mass (in kg)
(Supplementary Figure 4D). There were 257 genes associated
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FIGURE 2 | Association between changes in IS and factors in host, microbiota, and lifestyle. (A,B) Superimposed PLSR networks associated with change in insulin
sensitivity (1INS. SEN.), where nodes are arranged by (A) betweenness centrality and (B) variable type. The green edges correspond to positive correlations of
change and the red edges correspond to negative correlations of change. (C) Summary of variables from host, microbiota, and lifestyle factors associated with
1INS. SEN. Association coefficient threshold = [0.7] for lifestyle factors, and | 0.75| for metabolomics and sAT gene expression. NA, not annotated; BCAAs,
branched chain amino acids; AAAs, aromatic amino acids; AAs, amino acids; MGS, metagenomic species. No association with change in physical activity or food
groups was found above the selected threshold.
with these clinical factors (summarized in Figure 2C and listed
in Supplementary Table 4).
In summary, this PLSR analysis, where we have applied
stringent association coefficient thresholds, has resulted in the
identification of a large set of factors (N = 565) from multiple
sources that are connected to changes in IS after CR.
Data Reduction and Integration: Novel
Connections Between Insulin Sensitivity,
BCAA and DDRGK1, an Adipocyte
Expressed Gene Involved in Protein
Ubiquitination
Our next objective was to gain a deeper insight into these
large sets of interactions between variables and highlight novel
connections based on the strongest associations between in
CR-induced changes in IS, metabolic features, sAT genes
and MGS. To reduce the number of features, we examined
the top 20% associations which was a trade-off between
stringency and retention of strong associations with change in IS
(Supplementary Table 5).
We used ScaleNet, a network learning approach based on
SCS, developed by our group (Affeldt et al., 2016), to examine
and visualize the strongest statistical dependencies between CR-
induced IS changes and the selected variables. The data reduction
approach led to focus on the following features: three nutrients
(carbohydrate in % of energy intake, fiber in grams, and alcohol
in grams), MGS (three species with highest prevalence in subjects,
namely GU:41 from the Clostridiales order, GU:84 from the
Alistipes genus, and GU:228 which is not annotated but whose
strongest hit from the gene catalog is Faecalibacterium sp.), 22
serum metabolic features, 19 urine metabolic features, 24 fecal
metabolic features, the markers of IS, adipocyte diameter, NEFA,
and 32 sAT genes.
ScaleNet thus established statistical dependencies between
these variables based on the consensus taken from different
network reconstruction approaches. The dependencies derived
through ScaleNet are therefore more robust than if any one single
network reconstruction method were used. These statistical
dependencies represent the pairwise mutual information between
variables, and so they capture both linear and non-linear
relationships.
As shown in Figure 3A, the reconstructed network is
composed of a large cluster (top) and several smaller clusters
not connected to the large cluster (bottom). This network
showed several within-class modules, such as for fecal metabolic
features for which a distinct cluster of nodes (variables) can
be seen, sAT genes, or serum metabolic features, where several
features corresponding to serum glucose clustered together.
Importantly, we observed statistical dependencies depicting
already established connections between classes of variables
(Figure 3A). Indeed, the IS markers that clustered together were
strongly connected with a serum BCAA cluster (leucine, valine,
and valine+ isoleucine).
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FIGURE 3 | Connection between change in IS, BCAAs and other factors from host, lifestyle, and microbiota. (A) ScaleNet network reconstruction showing how
changes in variables most strongly associated with improvements in IS are associated with each other. The green edges correspond to positive correlations of
change and the red edges correspond to negative correlations of change. (B) Change from baseline to week 6 in select variables from network (highlighted in
orange ellipse on the network in A). When significant, adjusted P-values (BH correction) from Wilcoxon Signed Rank test are shown. (C) Linear regression model,
where each section of the pie chart shows the relative contribution of change in selected variables (grouped by class) to change in revised QUICKI and HOMA-B.
Variables included in the model were those found in the main cluster of the network in part A (except serum metabolic features annotated as glucose). MGS,
metagenomic species; metab., metabolic features; DDRGK1, DDRGK domain containing 1 (also known as Dashurin).
This network showed a novel direct connection between
the sAT gene DDRGK1 (also known as UFM1-Binding
Protein 1, or UFBP1 or Dashurin) and three markers of
IS (glucose, HOMA-B, and revised QUICKI), as well as
with serum acetylcarnitine and GU:228 (unannotated, with
closest relevance to Faecalibacterium sp.), and an indirect
connection with other markers of IS and serum BCAA. The
DDRGK1 gene has not been previously explored in human
AT. Revisiting existing “in house” microarray data from obese
women (unpublished) revealed that DDRGK1 is 1.6-fold more
highly expressed in isolated adipocytes than stromal vascular
fraction in sAT (Supplementary Figure 6). To further examine
the relevance of this relationship between DDRGK1 and
IS variation, we explored another group of 27 overweight
and obese patients with comparable clinical characteristics
(unpublished data, Supplementary Table 6). Here, the subjects
had undergone a very low-calorie diet for 6 weeks followed
by a 6-week weight maintenance period, and DDRGK1
expression was examined after 12 weeks (Supplementary
Figure 7). After this weight maintenance phase, there was a
significant positive correlation of change between the revised
QUICKI and DDRGK1 expression in sAT (Supplementary
Figure 7C).
The changes in selected variables having dependencies with
the IS cluster is displayed in Figure 3B, showing a significant
decrease in serum BCAA and acetylcarnitine, a tendency to
decrease in DDRGK1, and no significant change in GU:228,
or unannotated urine and fecal metabolic features directly
connected with the IS cluster. The network also showed
dependencies between serum lysine and different elements
including blood glucose, unannotated fecal metabolic features, an
MGS from the Clostridiales order, and acetylcarnitine.
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Insulin Sensitivity Improvement After CR:
Important Contribution of Metagenomic
Species and Fiber Consumption in the
Diet
The ScaleNet network showing the statistical dependencies of
highly connected variables (Figure 3A) suggests that not only
lifestyle factors, fecal, urine, and serum metabolic features, but
also AT genes and gut microbiota composition contribute to
improvements in IS after CR. We then examined the relative
contribution of these elements to improved IS after CR. We
used linear regression and computed the inverse of the MSE by
variable class.
The pie charts on Figure 3C show that the greatest
contribution (around 50%) to improvement in revised QUICKI
and HOMA-B index came from change in abundance of the three
MGS included in the network, increase in dietary fibers and, in
the case of HOMA-B, change in concentration of fecal metabolic
features. Interestingly, there were similar contributions from sAT
gene expression (including DDRGK1) and selected serum and
urine metabolic features (between 5 and 17%). These results also
suggest important contributions by gut microbiota MGS and
dietary intake of fiber to improvements in IS.
DISCUSSION
In this study, we have identified novel links between host glucose
homeostasis, lifestyle factors and gut microbiota in the context
of a 6-week CR intervention. This is to our knowledge the
first study integrating information from lifestyle factors, gut
microbiota composition, clinical factors, sAT gene expression,
and metabolomics from serum, urine and feces, to investigate
their relationship with IS changes after CR. The variables that
were found to be more strongly associated with changes in IS
should be explored in future studies as potential biomarkers or
predictors of individual responses to this kind of intervention.
The analytical approach presented herein has led to: (1)
integration and visualization of multiple associations between
changes in gut microbiota, human omics data, lifestyle factors,
and IS; (2) reduction of data dimensionality to highlight key
variables of interest (from 9,986 variables to 115 variables
included in the ScaleNet reconstruction); (3) identification of a
robust inverse association between changes in circulating BCAA
with IS during CR; and (4) identification of new links between IS
and different elements such as those seen with metabolic features
in urine and feces, sAT genes and gut microbiota composition. (5)
Finally, we show an important contribution of MGS in improved
IS after CR in link with diet modulation.
Decreased Serum BCAA Associated
With Increased Insulin Sensitivity Are
Connected With Features From Host,
Lifestyle, and Gut Microbiota
One of the strongest associations with IS improvement was
a significant decrease in BCAA with CR (Figure 3B). This
differs from previous findings comparing metabolomics profiles
between a gastric bypass intervention and a weight-matched
dietary intervention (Laferrère et al., 2011). The authors observed
a decrease in BCAA and their metabolites in the surgical group,
concomitant with amelioration in IS. However, this was not the
case in the dietary intervention group. The baseline BMI for
this group was considerably higher than in our study group
(42.8 ± 3.8 vs. 34.0 ± 4.1 kg/m2, respectively), and their insulin
resistance markers remained higher than what we have observed
in this study after the dietary intervention. Therefore, greater
weight loss may have been necessary to yield significant decrease
in BCAA related to an improvement in IS, as shown in the present
study. Associations were identified not only between BCAA
and IS, but also with sAT gene expression, corroborating the
hypothesis of a potential role of sAT in insulin resistance through
inhibition of BCAA catabolism in AT which may accompany the
known alteration of other metabolic pathways, including mTOR
signaling in skeletal muscle, increase in gluconeogenesis, decrease
in glycolysis and β-oxidation, and increased mitochondrial stress
(Newgard et al., 2009; Herman et al., 2010; Roberts et al., 2014).
Our data integration and reduction approach led to
the identification of robust dependencies between the IS
markers/BCAA cluster in the ScaleNet network with DDRGK1,
a gene involved in protein ubiquitination. The relationship
between DDRGK1 and IS was confirmed in an independent
group of overweight/obese subjects following a different dietary
intervention setting. Indeed, this second group was explored
during a weight maintenance phase after a period of weight
loss. Thus the fact that AT gene expression profiles greatly vary
depending on the stage of weight loss and regain (Capel et al.,
2009; Piening et al., 2018) could account for the difference in the
direction of correlation between this study population and the
independent clinical group.
DDRGK1 has been shown to become activated and bind
to UFM1 in pancreatic beta cell lines for protection against
ER stress-induced apoptosis (Lemaire et al., 2011). There is
evidence in cell lines that DDRGK1 regulates NF-κB through
interaction with IκBα (Xi et al., 2013). Limited evidence is
available about this gene’s function in AT. We show here that
it is more highly expressed in isolated adipocytes than in the
stromal vascular fraction calling for deeper exploration of this
gene in adipocyte metabolic pathways. The ScaleNet network also
shows a link between DDRGK1 and an unannotated MGS whose
strongest alignment is with Faecalibacterium sp. Interestingly,
this microbial genus has been shown to be anti-inflammatory and
associated with IS (Sokol et al., 2008; Le Chatelier et al., 2013;
Munukka et al., 2014).
The network also showed elements from sAT, microbiota
composition and fecal and urine metabolomics connected to the
IS and BCAA cluster. Acylcarnitines are intermediates of fatty
acid oxidation that, when elevated, may be involved in lipid-
induced pathways of insulin resistance, although this hypothesis
has been questioned (Schooneman et al., 2013). Studies have
conversely shown that acetyl-L-carnitine supplementation leads
to improved IS in insulin-resistant overweight and obese
individuals (Ruggenenti et al., 2009). Acylcarnitines may also
derive from other metabolites, including ketone bodies, BCAA,
lysine and, in the case of acetylcarnitine, glucose. Acetylcarnitine,
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the two-carbon acylcarnitine, may be an indicator of glucose and
fatty acid catabolism status and has been previously associated
with insulin resistance (Schooneman et al., 2013). A recent
weight loss study in obese subjects showed that acylcarnitines,
including acetylcarnitine, were positively correlated with NEFAs
at baseline (Schooneman et al., 2016). In this study, contrary to
our findings and other published evidence (Ruggenenti et al.,
2009; Muoio et al., 2012), acetylcarnitine increased after a weight
loss intervention and was not correlated with IS. The design of
this study differed from ours in that it was a 12-week intervention
including a group on diet with physical activity and another
on pharmacological treatment. The differences in study design
(including diet) and effects induced on host metabolism from
these interventions could explain the discrepancies between
the studies. Here, concentration of acetylcarnitine decreased
significantly, and on the ScaleNet network (Figure 3A) it was
directly connected with DDRGK1, and indirectly connected with
BCAA, IS markers and a MGS from the Clostridiales order (GU:
41). This suggests a possible link between ER stress in sAT, and
insulin resistance-associated dysregulation of AT metabolism.
This hypothesis calls for confirmation in future studies, both
involving large human cohorts, as well as mechanistic exploration
in in vivo and in vitro models.
Cross-Talk Between Gut Microbiota
Composition and Insulin Sensitivity
After CR
The cross-talk between microbiota and metabolism in various
organs and tissues, including AT, has been described mostly
in mice but less so in humans (Tremaroli and Bäckhed, 2012;
Geurts et al., 2014; Fetissov, 2017). Even though we focused
our study on peripheral organs, there is current interest in the
cross-talk between gut microbiota and brain signaling (Wang
et al., 2018). Gut microbiota likely has a role in BCAA-
associated development of insulin resistance, as shown by
Pedersen et al. (2016), where a connection between circulating
BCAA, increased BCAA synthesis and decreased BCAA import
in microbiota was identified in insulin resistant adults. In
the same study, a causal role for gut microbiota in increase
of circulating BCAA and insulin resistance was suggested in
a mouse model. Consistently, our results demonstrate that a
reduction of caloric intake, body weight and improvement
in dietary quality results in a significant decrease in BCAA,
which is connected with improvement in IS and potentially
also sAT metabolism and protein ubiquitination, and with
compositional changes in the gut microbiota. The relative
contribution to circulating BCAA, as well as other metabolites,
from the gut microbiome and host and the degree of gut
permeability before and after weight loss interventions in human
obesity are to be considered in future studies (Genser et al.,
2018).
Challenges in Integration of Data With
High Dimensionality
A limitation of this study is the small sample size, an
issue generally encountered in studies using big data and
deep phenotyping. To circumvent this issue, we have used
stringent approaches in the different steps of the analysis,
including high thresholds for selection of relevant variables
and methods adapted to high dimensionality such as the
local reconstruction aspect of ScaleNet. The advantage of this
method is that it goes far beyond pairwise associations of
variables, taking into account all long-range associations within
subsets of variables, considering both linear and non-linear
relationships. This method is adapted to high-dimensional
settings since each reconstruction method uses many local
reconstructions based on a spectral setting. However, it is
important to note that the links we have identified need to be
corroborated by future research, including comparable study
designs and similar population characteristics. In fact, this
analytical approach will be applied to the Metacardis study
population1.
This study included only three men, which prevented the
assessment of sex differences in our outcomes. Future studies
should be balanced for gender to identify potential sex-specific
effects relevant in the treatment of obesity. Another limitation is
that some metabolic features included in this analysis could not
be annotated due to lack of knowledge in public databases and/or
limitations in the identification of low intensity metabolites, so
interpretation of these results could evolve depending on the
depth of our abilities to annotate further features.
The PLSR analysis takes into account pairwise associations
between two sets of variables rather than all possible connections
between and within both groups of variables. Our approach
started with a pairwise assessment of connections with IS in
order to prioritize variables of greatest relevance, followed by
the ScaleNet analysis, which included all possible connections
between these variables. However, the fact that we have initially
considered associations between two groups of variables at a
time (i.e., IS markers versus each block of variables), instead of
taking a more global approach, may have masked other important
connections between variables. Conversely, the approach we have
used makes the results more interpretable.
CONCLUSION
Our data integration approach has provided new insights and
revealed new associations between IS and AT genes, metabolites,
lifestyle factors, and microbiota during CR. Although here
we present some initial steps toward validation of our
observations, this approach should be repeated in other
populations with similar characteristics, and ideally with larger
sample sizes, to determine the robustness and reproducibility
of the more novel links we have identified. A recent study
has also taken a data integration approach to study multi-
omics associations during weight gain and weight loss, and
have uncovered connections between biomarkers and the gut
microbiota in individuals undergoing weight gain followed
by weight loss (Piening et al., 2018). Similarly to our
study, Piening et al. (2018) highlight connections between
1http://www.metacardis.net/
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IS status and circulating BCAA and acylcarnitines. It is
through reproducing such strategies in different studies that a
reliable and more complete picture of the connection between
obesity, metabolism, gut microbiota, and lifestyle factors will be
obtained.
This type of integrative approach should lead to innovative
applications for personalized care. Individual response profiles
from weight loss interventions could be optimized by targeting
markers of interest identified through this analysis. Data
integration has the potential for the development of personalized
approaches that would allow us to tackle obesity and other
associated cardiometabolic diseases.
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